This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA. 1965;193:646–50.
Epstein DH, Heilig M, Shaham Y. Science-based actions can help address the opioid crisis. Trends Pharmacol Sci. 2018;39:911–16.
Venniro M, Banks ML, Heilig M, Epstein DH, Shaham Y. Improving translation of animal models of addiction and relapse by reverse translation. Nat Rev Neurosci. 2020;21:625–43.
Farokhnia M, Faulkner ML, Piacentino D, Lee MR, Leggio L. Ghrelin: from a gut hormone to a potential therapeutic target for alcohol use disorder. Physiology & behavior. 2019;204:49–57.
Zhang Y, Nathan JB, Moreno A, Merkel R, Kahng MW, Hayes MR, et al. Calcitonin receptor signaling in nucleus accumbens D1R- and D2R-expressing medium spiny neurons bidirectionally alters opioid taking in male rats. Neuropsychopharmacology. 2023. https://doi.org/10.1038/s41386-023-01634-z. Online ahead of print.
We thank Dr. Yavin Shaham for comments and edits on the early version of the paper.
The research was supported by a grant from NIDA [DA047976] (MV).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Marino, R.A.M., Venniro, M. Calcitonin receptor signal: a potential target for opioid use disorder?. Neuropsychopharmacol. 48, 1835–1836 (2023). https://doi.org/10.1038/s41386-023-01702-4